urothelial carcinoma

Showing 1 - 25 of 239

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy

Recruiting
  • Urothelial Carcinoma
  • Radiotherapy
  • +2 more
  • Beijing, China
  • +2 more
Nov 2, 2023

18F-LN1 PET/CT in Urothelial Carcinomas

Recruiting
  • Urothelial Carcinoma
    • Chengdu, Sichuan, China
      Departments of Nuclear Medicine, Sichuan Provincial People's Hos
    Nov 2, 2023

    Liquid Biospy for Urinary Cancers

    Recruiting
    • Urothelial Carcinoma
    • Genetic analysis on isolated cells
    • Milan, Italy
      Urology Department
    Nov 6, 2023

    Immunotherapy in Upper Tract Urothelial Carcinoma

    Not yet recruiting
    • Urothelial Carcinoma
    • Evaluation of anti-PD-(L)1 immunotherapy efficacy
    • (no location specified)
    Oct 27, 2023

    Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

    Not yet recruiting
    • Non Muscle Invasive Bladder Cancer
    • +3 more
    • Cretostimogene Grenadenorepvec
    • n-dodecyl-B-D-maltoside
    • (no location specified)
    Oct 30, 2023

    Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 19, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Hematuria, Urothelial Tumor, Urothelial Carcinoma Trial in Rotterdam (urine-first strategy)

    Recruiting
    • Hematuria
    • +3 more
    • urine-first strategy
    • Rotterdam, Netherlands
      SeARCH-trial Pijpers
    Aug 30, 2023

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 27, 2023

    Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

    Recruiting
    • Urothelial Carcinoma
    • +2 more
      • Recife, Pernambuco, Brazil
      • +6 more
      Jul 11, 2023

      Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center - Philadelphia
      Jun 27, 2023

      Urothelial Carcinoma Trial (Disitamab Vedotin, radiotherapy)

      Not yet recruiting
      • Urothelial Carcinoma
      • Disitamab Vedotin
      • radiotherapy
      • (no location specified)
      Jun 20, 2023

      Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

      Not yet recruiting
      • Urothelial Carcinoma
      • disitamab vedotin
      • +4 more
      • (no location specified)
      Jun 9, 2023

      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Not yet recruiting
      • Urothelial Carcinoma
        • (no location specified)
        Jun 5, 2023

        Urothelial Carcinoma Trial in New York (Naptumomab Estafenatox, Pembrolizumab, Obinutuzumab)

        Not yet recruiting
        • Urothelial Carcinoma
        • Naptumomab Estafenatox
        • +2 more
        • New York, New York
          Weill Cornell Medicine/NewYork-Presbyterian Hospital
        May 30, 2023

        A Prospective, Multi-center Study

        Not yet recruiting
        • Hematuria
        • Urothelial Carcinoma
        • urine sample collection
        • Shanghai, Shanghai, China
          Changhai Hospital
        May 29, 2023

        Stratification in Veterans Presenting With Microscopic Hematuria

        Not yet recruiting
        • Urothelial Carcinoma
        • Cxbladder urine test
        • Durham, North Carolina
          Durham VA Health Care System
        Jun 1, 2023

        Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

        Not yet recruiting
        • Urothelial Carcinoma
        • +7 more
        • Jelmyto (mitomycin) for pyelocalyceal solution
        • (no location specified)
        May 22, 2023

        Urothelial Carcinoma Trial in United States (Enfortumab Vedotin, Radical surgery)

        Not yet recruiting
        • Urothelial Carcinoma
        • Enfortumab Vedotin
        • Radical surgery
        • Basking Ridge, New Jersey
        • +6 more
        May 11, 2023

        Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

        Not yet recruiting
        • Melanoma
        • +5 more
        • RC198 Injection
        • Auchenflower, Queensland, Australia
          Research Site
        May 17, 2023

        Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

        Not yet recruiting
        • Relapse
        • +7 more
        • Visakhapatnam, Andhra Pradesh, India
        • +5 more
        May 7, 2023

        Melanoma, Urothelial Carcinoma Trial in China (QLF31907)

        Not yet recruiting
        • Melanoma
        • Urothelial Carcinoma
        • Beijing, Beijing, China
        • +5 more
        Apr 9, 2023